How one patient advocate turned landmark lightings into a growing platform for community, awareness and demands for better MCAS care in Canada.
Emily Foucault pictured with the CN Tower in Toronto on International Mastocytosis and Mast Cell Diseases Awareness Day on October 20, 2024.
01
Context
What shaped the work
Mast Cell Activation Syndrome is an under-recognized multisystem condition. People living with it can face long diagnostic journeys, limited clinical expertise, fragmented treatment and medical dismissal.
International Mastocytosis and Mast Cell Diseases Awareness Day on October 20 created an opportunity to make an often-invisible community publicly visible.
02
Emily's role
Where Emily contributed
Emily acted as a patient advocate, campaign organizer, writer, designer and public storyteller. Drawing on her own experience with MCAS, she independently secured the CN Tower's inaugural purple lighting for the awareness day in 2023.
03
Collaborative process
How the work happened
The campaign connected patients, caregivers, advocacy organizations, landmarks, public officials, media and international awareness efforts. When nonprofit support was required, Emily worked with Mast Cell Action in the United Kingdom while leading the Canadian campaign independently.
04
Contribution
From insight to action.
Initiated and led landmark outreach beginning with the CN Tower.
Expanded visibility to the Toronto Sign and Niagara Falls.
Designed campaign materials and a central information page.
Created customizable advocacy letters to government.
Coordinated social storytelling and the #MCASCanada campaign.
Organized a Toronto community gathering at Stackt Market.
Connected her own story to wider gaps in recognition, diagnosis and care.
05
Output
What resulted
The advocacy produced annual purple landmark lightings, public campaign resources, government letters, community storytelling, a Toronto gathering and published commentary about the Canadian MCAS care crisis.